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Conclusion: PrCA19.9 was a marker predicting OS and 
pattern of failure. ACT had positive impact on 5-year OS in 
pts with prCA19.9 > 353.1 U/ml. Our results suggest that 
prCA19-9 should be included in predictive models in order to 
customize treatments basing on prognostic factors of 
individual pts. Innovative treatments should be tested 
especially in pts with high prCA19.9 value. 
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Purpose or Objective: To investigated the frequency and 
location of regional recurrence of locally advanced 
adenocarcinoma of GEJ patients after curative resection and 
refine the clinical target volume (CTV) delineation of 
radiotherapy. 
 
Material and Methods: From 2009 to 2013, we 
retrospectively reviewed 1140 esophagogastric cancer 
patients treated in our institute. Patients who had curative 
resection, and were histopathologically diagnosed with 
locally advanced adenocarcinoma of GEJ (T3/4 or any N+) 
and confirmed of regional recurrence in follow-up CT images 
were selected into the analysis. First regional recurrence was 
recorded and one diagnostic radiologist with specialty of 
gastrointestinal tract investigated. The frequency and 
location of regional failure at each node station were 
analyzed according to Siewert types. Reference CT images 
was obtained from a healthy volunteer. We then delineated 
the epicenters of recurrence sites at the equivalent location, 
based on the same vessels of reference CT images compared 
with the recurrence CT images on Pinnacle treatment 
planning system. The combined contour of all recurrence 
sites was presented on a digitally reconstructed radiograph 
(DRR) image.  
 
Results: Regional recurrence was identified in 78 patients. 
The majority of recurrence occurred within 2 years of follow-
up (Median, 10.9 months). Of all, 35 (44.9%) patients were 
regional nodule failure (NF) only, 24 (38%) experienced 
regional NF simultaneous with distant failure, 11 (14.1%) 
were locoregional, and 8 (10.3%) had concurrent distant and 
locoreginal failure. The most common recurrent lymph nodes 
station were No.16 (62.8%), No. 9 (32.1%), No. 11 (24.4%), 
No. 8 (17.9%), No. 7 (16.7%), No. 112 (12.8%), No. 4 (12.8%) 
and No. 12 (10.3%), respectively. 11 patients (14.1%) had 
recurrence at mediastinal lymph nodes. There was significant 
difference of NF in No. 9 (42.2% vs 18.2%, P=0.027) between 
Siewert type II and III AEG, but no difference was observed in 
the other node stations. Different frequency and location of 
regional recurrence were shown by CT and digitally 
reconstructed radiograph (DRR) images. A three-dimensional 
(3D) atlas based on vessel delineation and distribution of 
regional recurrence was established. 
 
Conclusion: The most prevalent nodal recurrence in patients 
with adenocarcinoma of GEJ after curative resection was 
along the abdominal aorta, celiac artery and splenic artery. 
Our findings suggest a modified elective lymphatic nodal 
target volume for IMRT contours in those patients.  
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Purpose or Objective: Concerns have been raised regarding 
the toxicity of neoadjuvant chemoradiotherapy (nCRT) for 
esophageal cancer that could contribute to an increased risk 
of complications after subsequent esophagectomy such as 
anastomotic leakage. In this respect, radiation dose to the 
gastric fundus is of interest as this part of the stomach is 
used for the esophagogastric anastomosis after 
esophagectomy. The aim of this study was to determine the 
influence of neoadjuvant radiation dose to the gastric fundus 
on the risk of postoperative anastomotic leakage in patients 
with esophageal cancer undergoing nCRT followed by 
transthoracic esophagectomy. 
 
Material and Methods: Between 2012 and 2015, 97 
consecutive patients with esophageal cancer who underwent 
nCRT followed by transthoracic esophagectomy with cervical 
anastomosis were analyzed. The nCRT regimen consisted of a 
total radiation dose of 41.4 Gy in 23 fractions of 1.8 Gy in 5 
weeks combined with weekly intravenous administration of 
carboplatin and paclitaxel. The gastric fundus was 
retrospectively contoured on the pre-treatment planning CT. 
Within this contour, dose-volume histogram parameters were 
calculated and univariable and multivariable logistic 
regression analyses were used to determine their influence 
on the risk of anastomotic leakage.  
 
Results: In 25 patients (26%) anastomotic leakage occurred. 
The mean radiation dose to the gastric fundus was 
significantly higher in patients with versus without 
anastomotic leakage (median [interquartile range]: 35.6 Gy 
[20.2-39.9] versus 24.9 Gy [11.9-35.1], respectively; p=0.047, 
Table 1). A mean dose above versus below 31.4 Gy was 
associated with leakage rates of 43% versus 15%, 
respectively. Two typical examples of dose distributions in 
relation to the gastric fundus in patients with and without 
anastomotic leakage are depicted in Figure 1. Adjusted for 
potential confounders including tumor location, clinical T-
stage and radiation modality, the mean radiation dose to the 
gastric fundus remained significantly and independently 
associated with an increased risk of anastomotic leakage in 
multivariable analysis (adjusted odds ratio 1.05 per 1 Gy 
increase, 95% confidence interval: 1.003-1.10, p=0.035). 
Also, in patients with anastomotic leakage the minimum 
radiation dose, V25, V30, and V35 to the gastric fundus were 
significantly higher (Table 1).  
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Conclusion: Neoadjuvant radiation dose to the gastric fundus 
has a significant influence on the risk of postoperative 
anastomotic leakage in patients with esophageal cancer 
treated with nCRT followed by transthoracic esophagectomy 
and cervical anastomosis. This finding is important for clinical 
practice because it suggests that efforts should be made to 
minimize the radiation dose to the gastric fundus when 
planning neoadjuvant radiation treatment for esophageal 
cancer. 
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Purpose or Objective: The delineation of clinical target 
volume (CTV) is a crucial step) in radiation therapy 
procedure. Uncertainties are related to the availability of 
several contouring guidelines suggesting different subvolumes 
and anatomical limits in rectal cancer. Furthermore, 
individual training creates large inter-operator variability in 
delineation. An international consensus among expert 
radiation oncologists might significantly reduce this 
variability. The definition of the procedures needed to 
produce consensus guidelines for rectal cancer through 
Falcon, the educational web-based multifunctional platform 
for delineation endorsed by ESTRO, was the primary aim of 
this study 
 
Material and Methods: Seven skilled radiation oncologists, 
delegated from ESTRO,ASTRO, TROG,EORTC, defined the 
steps to produce consensus rectal cancer guidelines on 
elective nodal level delineation during a preliminary meeting 
held in August 2014. Step 1: six rectal cancer cases with 
different clinical stage were chosen and the related CT scans 
were shared and unanimously approved. Step 2: the experts 
firstly delineated online the selected CT scan slices following 
each his own approved guidelines. Step 3: Meeting on person 
to discuss the first delineation outcome, with also surgeon 
and radiologist ad hoc invited. Step 4: all the experts had to 
delineate online the same CT scan slices, based on the new 
table of boundaries. Step 5: Peer review meeting to evaluate 
the final outcome and to define the publication plan. the 
degree of agreement was evaluated through the EduCause 
™STAPLE algorithm (ECSa). Step 6: preparation of the cases in 
Falcon to allow a free consultation after the publication of 
the guidelines 
 
Results: Falcon platform allowed to succeed in any steps: 
selection and upload of the proper CT scans proposed among 
the experts leaving different countries; optimal compliant of 
all expert their delineation exercise; the possibility to review 
and share the online delineation, to support the discussion by 
telephone conference.Some Falcon's features were 
considered significant to compare concurrently all the 
experts’ delineations, allowing to identify critical nodal 
boundaries as areas of disagreement. ì Furthermore the ECSa, 
has allowed to evaluate during the validation step the degree 
of agreement where the shared voxels between experts' 
delineations are graphically represented through an area with 
different levels of confidence (from 85% to 100%) for each 
structure set.  
 
 
 
Conclusion: The ESTRO’s Falcon platform of delineation 
showed to be a valuable tool in the definition of consensus 
guidelines for rectal cancer. These procedures might be 
reproduced to support the validation, discussion and 
comparison of delineations among skilled radiation 
oncologists to converge to consensus guidelines also for other 
scenarios. 
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Purpose or Objective: The standard treatment for locally 
advanced rectal cancer is radio(chemo)therapy (RCT) 
followed by total mesorectal excision (TME) surgery. Patients 
who achieve a good response to RCT may be offered less 
invasive surgery such as local excision or even no surgery at 
all. Before such a policy could be safely implemented, 
precise selection of the eligible patients is mandatory. This 
study identifies the pretreatment clinical factors that are 
associated with pathological complete response (pCR) and 
ypT0-1N0 and evaluates their performance as a tool to select 
patient for organ-preserving treatment strategies. 
 
